课题基金 / 基金详情

HIV-1 GENETIC VARIATION IN INFECTED HEMOPHILIACS OVER TIME

HIV-1 GENETIC VARIATION IN INFECTED HEMOPHILIACS OVER TIME
感染血友病患者的 HIV-1 基因随时间的变化
批准号:
5201572
负责人:
S J O'BRIEN
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

S J O'BRIEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Following infection by HIV-1, there is considerable variation in duration of the latency period, host immunological response, and the rate of CD4 T-cell decline. Three possible causes of the variability observed in outcome to HIV-1 infection may be cofactors such as other viruses, host genetic differences, and variants within the HIV-1 swarm. The goal of this project is to analyze the extent and pattern of HIV-1 sequence divergence over the course of infection in four stable, non-progressors and four rapid progressors whose CD4 T-cell count declined more than 75% in the first 24 months following enrollment into the Hemophilia Growth and Development Study. The study is comparing the quantitative and qualitative differences over time in viral sequences between these two dichotomous groups by using nested polymerase chain reaction (PCR) to amplify selected regions of env, gag, pol, and nef from cDNA obtained by reverse transcriptase PCR of plasma virion RNA, DNA from integrated provirus, and virus isolates. The PCR products of viral sequences (obtained from peripheral mononuclear blood cells, plasma, and isolates) are cloned and the nucleotide sequences from each patient from baseline through visit seven are compared. Progress to date includes the successful sequencing and preliminary phylogenetic analysis of clones from two fast and two slow progressors at seven time points for the V3 loop of the env.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GENETIC ANALYSIS OF HUMAN CELLULAR GENES IN NEOPLASTIC TRANSFORMATION
IDENTIFICATION OF HUMAN GENETIC LOCI WHICH INFLUENCE SUSCEPTIBILITY TO HIV
GENETIC ANALYSIS OF HUMAN CELLULAR GENES IN NEOPLASTIC TRANSFORMATION
MOLECULAR GENETIC ANALYSIS OF FELINE CELLULAR GENES--A COMPARATIVE APPROACH
海外基金